Rx Name [OCTREOTIDE, 9292]

OCTREOTIDE 0.1MG/ML INJ (DIL/AHI)
9292
OTHER THERAPEUTIC AGENTS
Symptomatic management of neuroendocrine tumours.
Anorexia, nausea, vomiting, diarrhoea and steatorrhoea, abdominal discomfort, and flatulence.
Initially 50 micrograms 1–2 times a day , adjusted according to resp onse; increased to 200 micrograms 3 times a day.